68GaGa-RAYZ-8009

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug Name68GaGa-RAYZ-8009

Drug Alias Name[68Ga]Ga-RAYZ-8009

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide Radionuclide Conjugate

Mechanisms of ActionGlypican-3 modulators

TargetsGlypican-3

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUmc Utrecht

China Registration ClassN/A

Develop Information

Active CompaniesUmc Utrecht

Inactive CompaniesN/A

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A